Literature DB >> 8467620

Lymphoma developing in a patient with rheumatoid arthritis taking methotrexate.

B Taillan1, G Garnier, J Castanet, E Ferrari, A Pesce, P Dujardin.   

Abstract

We report one case of non-Hodgkin lymphoma in a patient, with a 30-year history of rheumatoid arthritis, taking low dose methotrexate weekly over a 10-month period. The mild immunosuppression that occurs with methotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing lymphoproliferative diseases, but coincidence cannot be excluded.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8467620     DOI： 10.1007/bf02231567

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  5 in total

1.  Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.

Authors:  L J Kinlen
Journal:  Am J Med       Date:  1985-01-21       Impact factor: 4.965

2.  Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate.

Authors:  M H Ellman; H Hurwitz; C Thomas; M Kozloff
Journal:  J Rheumatol       Date:  1991-11       Impact factor: 4.666

3.  Complications of immunosuppression associated with weekly low dose methotrexate.

Authors:  J B Shiroky; A Frost; J D Skelton; D G Haegert; M M Newkirk; C Neville
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

4.  Efficacy of low-dose methotrexate in rheumatoid arthritis.

Authors:  M E Weinblatt; J S Coblyn; D A Fox; P A Fraser; D E Holdsworth; D N Glass; D E Trentham
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

5.  Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

Authors:  P L Bailin; J P Tindall; H H Roenigk; M D Hogan
Journal:  JAMA       Date:  1975-04-28       Impact factor: 56.272
  5 in total
  5 in total

Review 1.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 2.  Early development of Hodgkin's lymphoma in association with the use of methotrexate for the treatment of dermatomyositis.

Authors:  B Bittar; C D Rose
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

3.  Use of methotrexate in older patients. A risk-benefit assessment.

Authors:  S E Tett; E J Triggs
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

4.  Methotrexate for steroid-resistant systemic lupus erythematosus.

Authors:  M Hashimoto; S Nonaka; E Furuta; T Wada; Y Suenaga; M Yasuda; M Shingu; M Nobunaga
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

Review 5.  The Dual Role of Platelets in the Cardiovascular Risk of Chronic Inflammation.

Authors:  Carlos Zamora; Elisabet Cantó; Sílvia Vidal
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.